liver X receptor response element;
nuclear hormone receptor;
p38 mitogen-activated protein kinase;
transcriptional co-activator;
D O I:
暂无
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Peroxisome-proliferator-activated receptor (PPAR) gamma co-activator 1alpha (PGC-1alpha/PPARGC1) plays an important role in energy metabolism by co-ordinating transcriptional programmes of mitochondrial biogenesis, adaptive thermogenesis and fatty acid beta-oxidation. PGC-1alpha has also been identified to play a role in the intermediary metabolism by co-activating key transcription factors of hepatic gluconeogenesis and glucose uptake in muscles. In the present study, we show that PGC-1alpha serves as a co-activator for the liver X receptor (LXR) alpha, known to contribute to the regulation of cellular cholesterol homoeostasis. In transient transfection studies, PGC-1alpha amplified the LXR-mediated autoregulation of the LXRalpha promoter in a human brown adipocyte line and in 3T3-L1 cells via an LXR response element described previously. LXR-mediated transactivation via a natural LXR response element from the cholesteryl ester transfer-protein gene promoter was also enhanced by PGC-1alpha in a ligand-dependent manner. Mutational analysis showed that the LXXLL signature motif (L2) of PGC-1alpha was essential for coactivation of LXR-mediated transcriptional responses. This motif is located in the vicinity of the binding region for a putative repressor described previously. The repressor sequesters PGC-1alpha from PPARalpha and the glucocorticoid receptor, and this repressor did not interfere with PGC-1alpha-mediated co-activation of LXR-dependent gene transcription. Moreover, inhibition of p38 mitogen-activated protein kinase signalling, shown to abolish the co-activation of PPARalpha by PGC-1alpha, had only a moderate inhibitory effect on the co-activation of LXR. These results identify PGC-1alpha as a bona fide LXR co-activator and implicate distinct interfaces of PGC-1alpha and/or additional cofactors in the modulation of LXR and PPARalpha transcriptional activities.
机构:Glaxo Wellcome Inc, Res & Dev, Div Chem, Dept Struct Chem, Res Triangle Pk, NC 27709 USA
Nolte, RT
Wisely, GB
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Inc, Res & Dev, Div Chem, Dept Struct Chem, Res Triangle Pk, NC 27709 USA
Wisely, GB
Westin, S
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Inc, Res & Dev, Div Chem, Dept Struct Chem, Res Triangle Pk, NC 27709 USA
Westin, S
Cobb, JE
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Inc, Res & Dev, Div Chem, Dept Struct Chem, Res Triangle Pk, NC 27709 USA
Cobb, JE
Lambert, MH
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Inc, Res & Dev, Div Chem, Dept Struct Chem, Res Triangle Pk, NC 27709 USA
Lambert, MH
Kurokawa, R
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Inc, Res & Dev, Div Chem, Dept Struct Chem, Res Triangle Pk, NC 27709 USA
Kurokawa, R
Rosenfeld, MG
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Inc, Res & Dev, Div Chem, Dept Struct Chem, Res Triangle Pk, NC 27709 USA
Rosenfeld, MG
Willson, TM
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Inc, Res & Dev, Div Chem, Dept Struct Chem, Res Triangle Pk, NC 27709 USA
Willson, TM
Glass, CK
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Inc, Res & Dev, Div Chem, Dept Struct Chem, Res Triangle Pk, NC 27709 USA
Glass, CK
Milburn, MV
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Inc, Res & Dev, Div Chem, Dept Struct Chem, Res Triangle Pk, NC 27709 USAGlaxo Wellcome Inc, Res & Dev, Div Chem, Dept Struct Chem, Res Triangle Pk, NC 27709 USA